Loading company…
Riskpilot
← Back to search
Sign in
Get full access
iobio Holding ApS
APS
Active
CVR 43598716
Hellebækgade 17, 2.
Research and experimental development on natural sciences and engineering · NACE 7210
Est. 2022
— employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2025
—
EBITDA margin
—
Equity ratio
100.0%
Financial strength
Net profit 2025
DKK -2K
+55% vs 2024
EBITDA — year on year
DKK millions
0M
-0M
-1M
-1M
-1M
0M
2023
0M
0%
2024
0M
0%
2025
Key figures
Annual report 2025
Revenue
—
—
EBITDA
DKK 0
—
Net profit
DKK -2K
+55%
Total assets
DKK 31K
-7%
Equity
DKK 31K
-7%
Employees
—
—
Company information
Legal name
iobio Holding ApS
CVR number
43598716
Legal form
Anpartsselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
17. oktober 2022
Share capital
DKK 40.000
Employees
—
VAT registered
No
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Virksomheden tegnes af den administrerende direktør
Company purpose
Anpartsselskabet bruges som et holdingselskab med særligt formål at fungere som ejer af virksomheder hvori der investeres.
Contact
Address
Hellebækgade 17, 2.
Email
michaelkroghjensen@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Research and experimental development on natural sciences and engineering
Companies in København
All Denmark companies
Revenue
DKK millions
0M
0M
1M
1M
1M
0M
2023
0M
2024
0M
2025
EBITDA
DKK millions
0M
0M
1M
1M
1M
0M
2023
0M
2024
0M
2025
Income statement
DKK thousands
Item
2023
2024
2025
Revenue
—
—
—
Staff expenses
-0
-0
-0
EBITDA
0
0
0
Depreciation & amort.
-0
-0
-0
EBIT
0
0
0
Net financials
-2
-5
-2
Profit before tax
-2
-5
-2
Tax
-0
-0
-0
Net profit
-2
-5
-2
Balance sheet
DKK thousands
Item
2023
2024
2025
Total assets
38
33
31
Equity
38
33
31
Long-term debt
0
0
0
Short-term debt
0
0
0
Total debt
0
0
0
Financial ratios
5-year trend
EBITDA margin
0.0%
This company
15.8%
Market median
-100% vs market
2023
2025
Equity ratio
100.0%
This company
38.2%
Market median
+162% vs market
2023
2025
Return on equity
-8.1%
This company
18.4%
Market median
-144% vs market
2023
2025
Net profit margin
-246000.0%
This company
8.1%
Market median
-3037137% vs market
2023
2025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2023
2025
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
2023
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2024-07-01 – 2025-06-30
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2023-07-01 – 2024-06-30
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2022-10-17 – 2023-06-30
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
MK
Michael Krogh Jensen
Chief Executive Officer
Chief Executive Officer
2022
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
iobio Holding ApS
(this company)
Biomia ApS
Board network connections
Board members of iobio Holding ApS also hold positions in
0
other companies.
Person
Role here
Other companies
Michael Krogh Jensen
Chief Executive Officer
0 companies